Skip to content
10-K

Annual Report

CHINA BCT PHARMACY GROUP, INC.

0001213900-13-001803

← back to feed
Filed
Apr 15, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2012 · Mar 26, 2013 38.15M sh
Shares Diluted FY 2012 · Dec 31, 2012 38.15M sh
Capex FY 2012 · Dec 31, 2012 $5.76M
Operating Cash Flow FY 2012 · Dec 31, 2012 −$9.59M
Long Term Debt FY 2012 · Dec 31, 2012 $202.06K
Long Term Debt FY 2012 · Dec 31, 2011 $2.02M
Short Term Debt FY 2012 · Dec 31, 2012 $15.86M
Short Term Debt FY 2012 · Dec 31, 2011 $7.23M
Cash And Equivalents FY 2012 · Dec 31, 2012 $21.61M
Current Liabilities FY 2012 · Dec 31, 2012 $73.48M
Total Liabilities FY 2012 · Dec 31, 2012 $73.76M
Current Assets FY 2012 · Dec 31, 2012 $199.52M
Total Assets FY 2012 · Dec 31, 2012 $244.97M
Sga Expense FY 2012 · Dec 31, 2012 $11.71M
Net Income FY 2012 · Dec 31, 2012 $21.05M
Net Income FY 2012 · Dec 31, 2011 $31.19M
Operating Income FY 2012 · Dec 31, 2012 $29.39M
Gross Profit FY 2012 · Dec 31, 2012 $48.68M
Cost Of Revenue FY 2012 · Dec 31, 2012 $193.18M
Revenue FY 2012 · Dec 31, 2012 $241.87M